Enzyme vs Horizen — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Horizen trades at Rp71,240 (market cap Rp2,29T, Rp96,68M 24h volume). The key difference: Horizen is far larger — about 17073× Enzyme's market cap, and Horizen's supply is capped (15,1M / 21M ZEN (72%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 29 Days and Horizen for 81 Days on average.
| MLN | ZEN | |
|---|---|---|
Market Cap | Rp134,13M | Rp2,29T |
Volume (24h) | Rp104,56M | Rp96,68M |
Circulating Supply | 3,3M MLN | 15,1M / 21M ZEN (72%) |
Typical Hold Time | 29 Days | 81 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Horizen (ZEN) is currently trading at Rp72,629 with a market cap of Rp2.29T, showing bearish technical signals with 16 sell signals versus 4 buy signals. The token trades near its pivot point of Rp72,502 with key support at Rp71,121 and resistance at Rp73,390. With 72% of the 21 million max supply in circulation and an average hold time of 81 days, the network shows moderate distribution maturity.
Overall outlook remains cautious with bearish momentum dominating technical indicators. Key opportunities include potential bounce from support levels, while risks include continued downward pressure and limited recent protocol developments. Investors should monitor volume patterns and broader crypto market sentiment for directional cues.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Horizen (ZEN) is a zero-knowledge-enabled network of blockchains powered by the largest node infrastructure in the industry. Blockchain interoperability is enabled by the Zendoo protocol, which uses SNARK-verification and allows for complete flexibility in sidechain type, consensus, speed, and privacy.
Read more on ZEN →